powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023303096
Hossein Maymani
MD
Hematology-Oncology
Longmont,
CO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 060003
Hospital
CCN 060027
Hospital
CCN 060119
Hospital
CCN 060128
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,110
Unique beneficiaries
—
Total services
55,548
Distinct HCPCS
66
Medicare payment
$828K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 118 Hematology-Oncology providers in CO — top quintile (cohort median 956).
QUALITY · MIPS · 2024
Final MIPS score
73.3
Quality
59.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
72.0
Payment adjustment
-0.20%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
707
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
25
Brand share
28.7%
Top prescribed drugs
Prednisone
86 claims
Abiraterone Acetate
84 claims
Apixaban
65 claims
Hydroxyurea
62 claims
Prochlorperazine Maleate
40 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.